Race Is Associated With Discontinuation of Active Surveillance of Low-Risk Prostate Cancer: Results From the Duke Prostate Center

Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/pcan.2012.38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Active Surveillance in Intermediate Risk Prostate Cancer: Is It Safe?

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2016English

Is There Any Association Between Prostate-Specific Antigen Screening Frequency and Uptake of Active Surveillance in Men With Low or Very Low Risk Prostate Cancer?

BMC Urology
MedicineReproductive MedicineUrology
2019English

Active Surveillance in Prostate Cancer

Üroonkoloji Bülteni
2017English

Evaluation and Active Treatment Versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer

Journal of Urology
Urology
2019English

Active Surveillance for Prostate Cancer

International Journal of Urology
Urology
2015English

Expending the Paradigm: Active Surveillance for Intermediate Risk Prostate Cancer

Open Journal of Urology
2018English

When Is Active Surveillance the Appropriate Treatment for Prostate Cancer?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Prostate Cancer: A Review of Active Surveillance

Research and Reports in Urology
Urology
2014English

Pi-02 a Systematic Approach to Discussing Active Surveillance to Patients With Low-Risk Prostate Cancer

Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy